产品
编 号：F372970
分子式：C17H24O11
分子量：404.37
分子式：C17H24O11
分子量：404.37
产品类型
规格
价格
是否有货
1mg
询价
询价
5mg
询价
询价
10mg
询价
询价
20mg
询价
询价
结构图
CAS No: 50816-24-5
产品详情
生物活性：
Hastatoside is an iridoid glycoside that is isolated from Verbena officinalis and has a role in promoting sleep.
体内研究：
Hastatoside (0.32-0.64 mmol/kg; oral administration; for 9 hours; male rats of the Sprague-Dawley strain)treatment increases the total time of non-rapid eye movement sleep during a 9-h period, with a lag time of about 3-5 h after the administration at 20. 00 hours (lights-off time). Hastatoside also increases the delta activity during non-rapid eye movement sleep.Animal Model:Male rats of the Sprague-Dawley strain (8 weeks old; 260-280 g)
Dosage:0.32 mmol/kg, 0.48 mmol/kg, 0.64 mmol/kg
Administration:Oral administration; for 9 hours
Result:Increased the total time of non-rapid eye movement sleep during a 9-h period, with a lag time of about 3-5 h after the administration at 20. 00 hours (lights-off time). Also increased the delta activity during non-rapid eye movement sleep.
Hastatoside is an iridoid glycoside that is isolated from Verbena officinalis and has a role in promoting sleep.
体内研究：
Hastatoside (0.32-0.64 mmol/kg; oral administration; for 9 hours; male rats of the Sprague-Dawley strain)treatment increases the total time of non-rapid eye movement sleep during a 9-h period, with a lag time of about 3-5 h after the administration at 20. 00 hours (lights-off time). Hastatoside also increases the delta activity during non-rapid eye movement sleep.Animal Model:Male rats of the Sprague-Dawley strain (8 weeks old; 260-280 g)
Dosage:0.32 mmol/kg, 0.48 mmol/kg, 0.64 mmol/kg
Administration:Oral administration; for 9 hours
Result:Increased the total time of non-rapid eye movement sleep during a 9-h period, with a lag time of about 3-5 h after the administration at 20. 00 hours (lights-off time). Also increased the delta activity during non-rapid eye movement sleep.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备